EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Combination of Intravenous and Topical Tranexamic Acid in Decreasing Intra-operative Haemorrhage in Transurethral Resection of Prostate: A Randomized Controlled Trial

Disha R. Lathe, Navdeep Kaur, M. S. Manisha Singh, B. Yatish

Sri Lankan Journal of Anaesthesiology · 20.11.2026 · 34 (3) · 371-378

DOI: 10.4038/slja.v34i3.9691 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Sri Lankan Journal of Anaesthesiology, online erschienen am 20.11.2026. Verfasst von Disha R. Lathe und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Transurethral resection of the prostate (TURP) continues to be the gold-standard surgical procedure for managing benign prostatic hyperplasia (BPH). However, significant intraoperative bleeding, attributed to the prostate’s rich vascular supply, continues to pose challenges. Tranexamic acid (TXA), an antifibrinolytic agent, has shown promise in minimizing surgical blood loss. This study focused on assessing the efficacy and safety of combined intravenous and topical TXA administration in reducing intraoperative hemorrhage during TURP.Methodology: A randomized controlled trial was conducted involving 80 eligible male patients undergoing TURP. Participants were randomly allocated into two groups: the intervention group received both intravenous and topical TXA, while the control group received no TXA. Intraoperative blood loss was evaluated by measuring changes in hemoglobin levels. Secondary outcomes included volume of irrigation fluid used, operative duration, and adverse events such as deep vein thrombosis or thromboembolism. Patients were followed for 24 hours postoperatively. Statistical analysis was performed using t-tests and chi-square tests, with p < 0.05 considered significant.

Results

Baseline characteristics were comparable between groups. Patients in the TXA group had a significantly lower postoperative hemoglobin drop (−5.57% vs. −7.77%, p = 0.0013) and reduced estimated blood loss (290 mL vs. 400 mL, p < 0.001) compared to the control group. No significant difference in adverse events was observed between the two groups.

Conclusion

Combined intravenous and topical tranexamic acid significantly reduces intraoperative blood loss and postoperative hemoglobin drop during TURP without increasing the risk of adverse events. These results support the use of TXA as a safe and effective hemostatic adjunct in TURP.

Zitieren

APA

Lathe, D. R., Kaur, N., Singh, M. S. M., & Yatish, B. (2026). Combination of Intravenous and Topical Tranexamic Acid in Decreasing Intra-operative Haemorrhage in Transurethral Resection of Prostate: A Randomized Controlled Trial. Sri Lankan Journal of Anaesthesiology, 34(3), 371-378. https://doi.org/10.4038/slja.v34i3.9691

Vancouver

Lathe DR, Kaur N, Singh MSM, Yatish B. Combination of Intravenous and Topical Tranexamic Acid in Decreasing Intra-operative Haemorrhage in Transurethral Resection of Prostate: A Randomized Controlled Trial. Sri Lankan Journal of Anaesthesiology. 2026;34(3):371-378. doi:10.4038/slja.v34i3.9691

BibTeX
@article{Lathe2026,
  author = {Lathe, Disha R. and Kaur, Navdeep and Singh, M. S. Manisha and Yatish, B.},
  title = {Combination of Intravenous and Topical Tranexamic Acid in Decreasing Intra-operative Haemorrhage in Transurethral Resection of Prostate: A Randomized Controlled Trial},
  journal = {Sri Lankan Journal of Anaesthesiology},
  year = {2026},
  volume = {34},
  number = {3},
  pages = {371--378},
  doi = {10.4038/slja.v34i3.9691}
}
Kostenlos starten →